Kiora Pharmaceuticals has granted Senju Pharmaceutical an exclusive option to exercise rights to an exclusive development and ...

These promoters drive strong and specific gene expression in rod and cone photoreceptors even in mid-to-late stages of disease, outperforming most currently used promoters in retinal gene therapy.

"By decoding the molecular structure of velvet worm slime, we're now one step closer to replicating that efficiency for the materials we use every day." Velvet worms, small caterpillar-like ...

STONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), ...

Now, in a study published in Molecular Therapy, researchers from the Division of Experimental Retinal Therapies at the University of Pennsylvania's School of Veterinary Medicine (Penn Vet ...

Terra Innovatum’s SOLO™ Micro-Modular Reactor Offers Safe, Affordable, and Reliable 24/7 Power Without Refueling for 15 Years Using Off-the-Shelf Readily Available Commercial Components and Licensed ...

Once tagged, the proteins are sent to the proteasome—a cellular structure Arnold likens to ... Without their molecular scaffolding, the synapses fall apart and the neuron cannot transmit the ...

High-profile news coverage that eLife papers generated in April 2025, including Popular Science, Daily Express and LiveScience.

"Dry AMD is driven by a number of factors that contribute to the death of retinal cells, leading to irreversible vision loss," stated Mary Hamby, PhD, vice president of research. "Preclinical ...